DODGE & COX, a registered investment adviser, initiated a new position in GSK plc (NYSE:GSK) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 68,517,969 shares of the Healthcare company, valued at approximately $3.4B as of the filing date.
GSK plc's stock currently trades at $59.77 with a market capitalization of $99.4B.
